Page last updated: 2024-08-24

turosteride and finasteride

turosteride has been researched along with finasteride in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	9 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ballard, S; Blagg, J; Fox, D; Kenny, B	1
Délos, S; Guirou, O; Iehlé, C; Martin, PM; Raynaud, JP; Tate, R	1
Broutin, F; Fontana, E; Fonte, G; Panzeri, A; Persiani, S; Pianezzola, E; Strolin Benedetti, M	1
Briatico, G; Di Salle, E; Giudici, D; Ornati, G; Panzeri, A	2
Basileo, G; Casati, M; Pianezzola, E; Strolin Benedetti, M	1
di Salle, E; Giudici, D; Zaccheo, T	2
Ahmed, S; Denison, S	1

Reviews

1 review(s) available for turosteride and finasteride

Article	Year
Pharmacological options in the treatment of benign prostatic hyperplasia. Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship	1997

Article

Year

Pharmacological options in the treatment of benign prostatic hyperplasia.

Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9

Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship

1997

Trials

1 trial(s) available for turosteride and finasteride

Article	Year
Determination of turosteride, a new inhibitor of 5 alpha-reductase, in human plasma by high-performance liquid chromatography with ultraviolet detection. Journal of chromatography. B, Biomedical sciences and applications, 1997, Jan-10, Volume: 688, Issue:1 Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Administration, Oral; Animals; Chromatography, High Pressure Liquid; Circadian Rhythm; Dogs; Enzyme Inhibitors; Finasteride; Haplorhini; Humans; Male; Mice; Rats; Reproducibility of Results; Spectrophotometry, Ultraviolet; Time Factors	1997

Article

Year

Determination of turosteride, a new inhibitor of 5 alpha-reductase, in human plasma by high-performance liquid chromatography with ultraviolet detection.

Journal of chromatography. B, Biomedical sciences and applications, 1997, Jan-10, Volume: 688, Issue:1

Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Administration, Oral; Animals; Chromatography, High Pressure Liquid; Circadian Rhythm; Dogs; Enzyme Inhibitors; Finasteride; Haplorhini; Humans; Male; Mice; Rats; Reproducibility of Results; Spectrophotometry, Ultraviolet; Time Factors

1997

Other Studies

7 other study(ies) available for turosteride and finasteride

Article	Year
Human prostatic steroid 5 alpha-reductase isoforms--a comparative study of selective inhibitors. The Journal of steroid biochemistry and molecular biology, 1995, Volume: 54, Issue:5-6 Topics: Animals; Azasteroids; Binding, Competitive; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Enzyme Activation; Enzyme Inhibitors; Finasteride; Humans; Insecta; Isoenzymes; Male; Oxidoreductases; Prostate; Recombinant Proteins; Transfection	1995
Radioimmunoassay for the testosterone 5 alpha-reductase inhibitor turosteride in biological fluids. Journal of immunoassay, 1994, Volume: 15, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adult; Animals; Cross Reactions; Finasteride; Humans; Immune Sera; Male; Rabbits; Radioimmunoassay	1994
Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride (FCE 26073). The Journal of steroid biochemistry and molecular biology, 1994, Volume: 48, Issue:2-3 Topics: 3-Hydroxysteroid Dehydrogenases; 5-alpha Reductase Inhibitors; Adrenal Glands; Animals; Aromatase Inhibitors; Cholesterol Side-Chain Cleavage Enzyme; Dogs; Female; Finasteride; Humans; Male; Orchiectomy; Organ Size; Placenta; Prostate; Rabbits; Rats; Receptors, Steroid; Seminal Vesicles; Species Specificity	1994
Hormonal effects of turosteride, a 5 alpha-reductase inhibitor, in the rat. The Journal of steroid biochemistry and molecular biology, 1993, Volume: 46, Issue:5 Topics: 5-alpha Reductase Inhibitors; Animals; Dihydrotestosterone; Dose-Response Relationship, Drug; Finasteride; Humans; Luteinizing Hormone; Male; Orchiectomy; Organ Size; Prolactin; Prostate; Rats; Receptors, Androgen; Testosterone	1993
Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma. The Prostate, 1997, Feb-01, Volume: 30, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Flutamide; Leuprolide; Luteinizing Hormone; Male; Organ Size; Pituitary Gland, Anterior; Prostate; Prostatic Neoplasms; Random Allocation; Rats; Seminal Vesicles; Testis; Testosterone	1997
Effect of early treatment of prostate cancer with the 5alpha-reductase inhibitor turosteride in Dunning R3327 prostatic carcinoma in rats. The Prostate, 1998, Jun-01, Volume: 35, Issue:4 Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Animals; Cell Line; Drug Administration Schedule; Enzyme Inhibitors; Finasteride; Male; Orchiectomy; Organ Size; Prostate; Prostatic Neoplasms; Rats; Time Factors	1998
Mechanism based representation of the active site of 5 alpha-reductase (5AR). Bioorganic & medicinal chemistry letters, 1998, Sep-22, Volume: 8, Issue:18 Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Azasteroids; Binding Sites; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Models, Chemical; Models, Molecular; NADP; Pregnanes; Structure-Activity Relationship; Testosterone	1998